Mitochondria as cell targets of AZT (zidovudine)

被引:53
作者
Barile, M
Valenti, D
Quagliariello, E
Passarella, S
机构
[1] Univ Bari, Dipartmento Biochim & Biol Mol, I-70126 Bari, Italy
[2] CNR, Ctr Studio Mitocondri & Metab Energet, I-70126 Bari, Italy
[3] Univ Molise, Dipartimento Sci Anim Vegetali & Ambiente, Campobasso, Italy
来源
GENERAL PHARMACOLOGY | 1998年 / 31卷 / 04期
关键词
mitochondria; 3 '-azido-3 '-deoxythymidine (AZT); acquired immuno-deficiency syndrome; AZT toxicity;
D O I
10.1016/S0306-3623(98)00041-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The subject of this review is the interact:ion between AZT (zidovudine) and mitochondria as described in papers dealing with AZT therapy both in AIDS patients and in model systems-that is, in cultured cells and in isolated mitochondria. 2. The structure and function of mitochondria are briefly described with discussion of the theoretical frame for a detailed bioenergetic investigation. 3. Experimental work is reported showing that mitochondria are cell AZT targets: changes in the structure and function induced by long-term AZT therapy as investigated both in AIDS patients and in model systems. 4. The AZT inhibition of energy-supplying reactions is considered in detail in studies dealing with long-term treatment and studies in which AZT was added to isolated mitochondria. In particular, adenylate kinase, ADP/ATP translocase and DNA polymerase gamma are reported as molecular targets of AZT. 5. Some perspectives of AZT therapy from the study of the effect of AZT on mitochondrion biochemistry are briefly reported. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 56 条
  • [1] Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine
    Agarwal, RP
    Olivero, OA
    [J]. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 390 (03) : 223 - 231
  • [2] AGGARWAL A, 1996, MD MED J, V45, P929
  • [3] DEPLETION OF MUSCLE MITOCHONDRIAL-DNA IN AIDS PATIENTS WITH ZIDOVUDINE-INDUCED MYOPATHY
    ARNAUDO, E
    DALAKAS, M
    SHANSKE, S
    MORAES, CT
    DIMAURO, S
    SCHON, EA
    [J]. LANCET, 1991, 337 (8740) : 508 - 510
  • [4] ATLANTE A, INT J MOL MED, V1, P601
  • [5] BALZARINI J, 1989, J BIOL CHEM, V264, P6127
  • [6] MECHANISMS OF TOXICITY OF 3'-AZIDO-3'-DEOXYTHYMIDINE
    BARILE, M
    VALENTI, D
    HOBBS, GA
    ABRUZZESE, MF
    KEILBAUGH, SA
    PASSARELLA, S
    QUAGLIARIELLO, E
    SIMPSON, MV
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (07) : 1405 - 1412
  • [7] 3'-Azido-3'-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator
    Barile, M
    Valenti, D
    Passarella, S
    Quagliariello, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (07) : 913 - 920
  • [8] The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction
    Casademont, J
    Barrientos, A
    Grau, JM
    Pedrol, E
    Estivill, X
    UrbanoMarquez, A
    Nunes, V
    [J]. BRAIN, 1996, 119 : 1357 - 1364
  • [9] Chariot P, 1991, Neuromuscul Disord, V1, P357, DOI 10.1016/0960-8966(91)90122-9
  • [10] CONCURRENT ZIDOVUDINE-INDUCED MYOPATHY AND HEPATOXICITY IN PATIENTS TREATED FOR HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    CHEN, SCA
    BARKER, SM
    MITCHELL, DH
    STEVENS, SMB
    ONEILL, P
    CUNNINGHAM, AL
    [J]. PATHOLOGY, 1992, 24 (02) : 109 - 111